Skip to main content
. Author manuscript; available in PMC: 2015 Apr 1.
Published in final edited form as: J Immunol. 2014 Feb 21;192(7):3021–3028. doi: 10.4049/jimmunol.1302934

Figure 7.

Figure 7

Accelerated development of K/BxN serum induced arthritis in Fcgr2bfl/fl mice with LysMCre. WT, Fcgr2b−/−, Fcgr2bfl/fl mice with LysMCre, and FcγR-deficient (Fcer1g−/−Fcgr2b−/−) mice were treated with K/BxN sera and monitored for the development of arthritis. Arthritis clinical scores (mean±s.d) are presented. * p < 0.05, *** p < 0.001, ANOVA with Dunnett’s post hoc comparing each group to the “WT” group. Representative of two independent experiments.